Witherspoon Charles's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed Oct 31, 2024
- Accession no.
- 0001127602-24-026141
- Filed
- Oct 31, 2024
- Trade date
- Oct 29, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $218.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Witherspoon CharlesCIK 0001731739 | Officer (VP & Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2024 | Common Stock | MOption exerciseAcquired | +478 | $173.22 | +$82,799.16 | 1,956.14 | Direct | |
| Oct 29, 2024 | Common Stock | SSaleDisposed | −478 | $310.40 | −$148,371.2 | 1,478.14 | Direct | |
| Oct 29, 2024 | Common Stock | SSaleDisposed | −225 | $310.40 | −$69,840 | 1,253.14 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2024 | Stock Options (Right to Buy) | MOption exerciseDisposed | −478 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.